Susquehanna International Group
LTRN icon

Susquehanna International Group’s Lantern Pharma LTRN Stock Holding History

Susquehanna International Group’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,800
Closed -$121K – 12745
2024
Q1 		$121K Buy
+13,800
New +$73.7K ﹤0.01% 11087
2022
Q4 		– Sell
-33,500
Closed -$160K – 13145
2022
Q3 		$160K Buy
+33,500
New +$180K ﹤0.01% 11146
2022
Q1 		– Sell
-12,400
Closed -$99K – 13569
2021
Q4 		$99K Buy
+12,400
New +$113K ﹤0.01% 12158

Other funds holding LTRN

EAM
Empery Asset Management New York $86.5M AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Susquehanna International Group's LTRN Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Lantern Pharma (LTRN) in Q2 2026: 14,073 shares worth $58.7K. The stake represents ﹤0.01% of the portfolio and ranks #12768 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in LTRN as recently as Q4 2025.

Susquehanna International Group first reported a position in LTRN in Q3 2021 and has held it in 12 quarters since. The position peaked at $279K in Q2 2024. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Susquehanna International Group held 14,073 shares of Lantern Pharma worth $58.7K as of Q2 2026.
  • Lantern Pharma was a new Susquehanna International Group position in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12768 holding.
  • Susquehanna International Group first reported a position in Lantern Pharma in Q3 2021 and has held it in 12 quarters since.
  • Susquehanna International Group's Lantern Pharma position peaked at $279K in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.